Status:
UNKNOWN
Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants
Lead Sponsor:
China Medical University Hospital
Conditions:
Extremely Premature Infants
PDA
Eligibility:
All Genders
3-24 years
Phase:
PHASE1
PHASE2
Brief Summary
Background: Patent ductus arteriosus (PDA) continues to be one of the most common problems in premature infants. Pharmacological closure of PDA with intravenous (IV) indomethacin was first reported i...
Eligibility Criteria
Inclusion
- premature infants gestational age \< 28 weeks, respiratory distress syndrome requiring assisted ventilation, a PDA without other cardiac anomalies confirmed by echocardiography within 24 hours after birth,
Exclusion
- severe congenital anomalies or lethal cardiopulmonary conditions, and informed consent could be obtained from parents
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2012
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01149564
Start Date
December 1 2009
End Date
June 1 2012
Last Update
June 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan, 404